These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704 [TBL] [Abstract][Full Text] [Related]
3. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Lang H; Sotiropoulos GC; Frühauf NR; Dömland M; Paul A; Kind EM; Malagó M; Broelsch CE Ann Surg; 2005 Jan; 241(1):134-43. PubMed ID: 15622001 [TBL] [Abstract][Full Text] [Related]
4. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma. Yap AQ; Chen CL; Yong CC; Kuo FY; Wang SH; Lin CC; Liu YW; Lin TL; Li WF; Millan CA; Wang CC Surg Oncol; 2013 Mar; 22(1):55-60. PubMed ID: 23102615 [TBL] [Abstract][Full Text] [Related]
7. Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. El Rassi ZE; Partensky C; Scoazec JY; Henry L; Lombard-Bohas C; Maddern G Eur J Surg Oncol; 1999 Aug; 25(4):375-80. PubMed ID: 10419707 [TBL] [Abstract][Full Text] [Related]
8. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review. Gupta R; Togashi J; Akamatsu N; Sakamoto Y; Kokudo N Surg Today; 2017 Aug; 47(8):908-917. PubMed ID: 28124125 [TBL] [Abstract][Full Text] [Related]
9. Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection for intrahepatic cholangiocarcinoma. Lee W; Park JH; Kim JY; Kwag SJ; Park T; Jeong SH; Ju YT; Jung EJ; Lee YJ; Hong SC; Choi SK; Jeong CY Surg Endosc; 2016 Nov; 30(11):4835-4840. PubMed ID: 26902611 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of prognostic factors after curative resection for combined hepatocellular and cholangiocarcinoma]. Kim W; Lee JH; Kim YJ; Yoon JH; Suh KS; Lee KU; Jang JJ; Lee HS Korean J Gastroenterol; 2007 Mar; 49(3):158-65. PubMed ID: 18172344 [TBL] [Abstract][Full Text] [Related]
13. Resection of the liver and inferior vena cava for hepatic malignancy. Hemming AW; Mekeel KL; Zendejas I; Kim RD; Sicklick JK; Reed AI J Am Coll Surg; 2013 Jul; 217(1):115-24; discussion 124-5. PubMed ID: 23376028 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma. Kim SH; Park YN; Lim JH; Choi GH; Choi JS; Kim KS Eur J Surg Oncol; 2014 Aug; 40(8):976-81. PubMed ID: 24909336 [TBL] [Abstract][Full Text] [Related]
15. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. Roayaie S; Guarrera JV; Ye MQ; Thung SN; Emre S; Fishbein TM; Guy SR; Sheiner PA; Miller CM; Schwartz ME J Am Coll Surg; 1998 Oct; 187(4):365-72. PubMed ID: 9783782 [TBL] [Abstract][Full Text] [Related]
16. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Figueras J; Llado L; Valls C; Serrano T; Ramos E; Fabregat J; Rafecas A; Torras J; Jaurrieta E Liver Transpl; 2000 Nov; 6(6):786-94. PubMed ID: 11084070 [TBL] [Abstract][Full Text] [Related]
17. Combined resection of the liver and inferior vena cava for hepatic malignancy. Hemming AW; Reed AI; Langham MR; Fujita S; Howard RJ Ann Surg; 2004 May; 239(5):712-9; discussion 719-21. PubMed ID: 15082976 [TBL] [Abstract][Full Text] [Related]
18. Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Diagnosis and Prognosis After Resection or Transplantation. Wu CH; Yong CC; Liew EH; Tsang LL; Lazo M; Hsu HW; Ou HY; Yu CY; Chen TY; Huang TL; Concejero AM; Chen CL; Cheng YF Transplant Proc; 2016 May; 48(4):1100-4. PubMed ID: 27320566 [TBL] [Abstract][Full Text] [Related]
19. [Peripheral cholangiocarcinoma: results of surgical treatment]. Margarit C; Escartín A; Bellmunt J; Allende E; Bilbao I Gastroenterol Hepatol; 2006 Apr; 29(4):215-23. PubMed ID: 16584691 [TBL] [Abstract][Full Text] [Related]
20. Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma-Stereotactic radiofrequency ablation as a valuable addition to hepatic resection. Braunwarth E; Schullian P; Kummann M; Reider S; Putzer D; Primavesi F; Stättner S; Öfner D; Bale R PLoS One; 2022; 17(1):e0261136. PubMed ID: 34982804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]